You are here

StemCells

NeoStem To Create Value With Billion Dollar Potential

Seeking Alpha

Wed, 11/7/12 - 12:39 pm

Neuralstem Swinging For The ALS Fences

Seeking Alpha

Mon, 10/29/12 - 11:39 am

Nobel Prize Validates Recent Stem Cell Headlines

Seeking Alpha

Tue, 10/16/12 - 11:57 am

Baxter International

Here are 5 Biopharmaceutical Companies on the Rise

Wall St Cheat Street

Sat, 10/13/12 - 11:55 am

Ariad Pharmaceuticals

Sarepta Therapeutics

Amicus Therapeutics

Savient Pharmaceuticals May Continue To Run Higher

Seeking Alpha

Tue, 10/9/12 - 05:29 pm

Catalyst Pharmaceutical Partners

Hemispherx Biopharma

5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments

Seeking Alpha

Tue, 10/9/12 - 04:21 pm

Pluristem Therapeutics

Ariad Pharmaceuticals

Fabry's disease

Amicus Therapeutics

Lessons From Biotech's Best Third Quarter Stocks

TheStreet.com

Tue, 10/2/12 - 11:59 am

Peregrine Pharmaceuticals

Catalyst Pharmaceutical Partners

The Promising, Cheap, And Growing Cell Therapy Arena Continues To Outperform The Market

Seeking Alpha

Mon, 09/24/12 - 11:17 am

Interim Data In Spinal Cord Injury Driving STEM Higher; PSTI Reacting in Sympathy

Yahoo/Reuters

Tue, 09/4/12 - 11:51 am

Pluristem Therapeutics

human neural stem cells

spinal cord injury

StemCells' CEO Discusses Q2 2012 Results - Earnings Call Transcript

Seeking Alpha

Mon, 08/6/12 - 10:32 am

Are Stem Cells Becoming The Next Bull Market In The Biotech Space?

Seeking Alpha

Tue, 07/31/12 - 11:09 am

Bristol-Myers Squibb

One Stock To Buy, Two Avoids, And A Swing Trade From Last Week's Big Biotech News Movers

Seeking Alpha

Sat, 07/21/12 - 11:48 am

Pluristem Therapeutics

ONYX Pharmaceuticals

StemCells rockets 40% on Alzheimer's study

Marketwatch

Tue, 07/17/12 - 12:18 pm

Alzheimer's disease

Stem Cell Hype Has Yet To Breed Profits

Seeking Alpha

Tue, 05/22/12 - 09:03 am

Advanced Cell Technology

StemCells announces positive preliminary results for Pelizaeus-Merzbacher trial

The Fly on the Wall

Mon, 04/2/12 - 12:22 pm

Pelizaeus-Merzbacher disease

FACTBOX-Stem cell advances focus on heart, inflammation

Reuters

Mon, 12/5/11 - 12:25 pm

Fibrocell Science

StemCells, Inc. CEO Martin McGlynn Featured on Wall Street Reporter

Yahoo/GlobeNewswire

Sat, 09/24/11 - 12:42 pm

spinal cord injury

Roth Capital Partners Initiates Research Coverage of StemCells, Inc. With Buy Recommendation

Yahoo/GlobeNewswire

Sat, 08/27/11 - 12:55 pm

StemCells Reports a Q2 Net Loss of $4M or $0.29 per share

Seeking Alpha

Sat, 07/30/11 - 09:48 am

What's All the Fuss About Stem Cells?

Motley Fool

Fri, 07/15/11 - 01:10 am

Pages